Bliss GVS Pharma Ltd NSE:BLISSGVS:
BLISS GVS PHARMA LTD - RECEIVED AN INSPECTION CLOSURE REPORT FROM WORLD HEALTH ORGANIZATION
BLISS GVS PHARMA - PALGHAR FACILITY HAS BEEN CONFIRMED TO BE IN COMPLIANCE WITH GOOD MANUFACTURING PRACTICES
Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization
Earlier from Bliss Gvs Pharma
- Bliss GVS hits 20% upper circuit as Anupam Rasayan to acquire up to 43% stake for Rs 1,369 crore
- Anupam Rasayan enters formulations business with ₹1,369 cr Bliss GVS Pharma acquisition
- BLISSGVS: Double-digit revenue and profit growth, strong margins, and expansion in global markets
- Anupam Rasayan India Denies Plans To Buy Stake In Bliss GVS Pharma